Celularity Inc. Announces $2 Million Private Placement with Institutional Investor for Working Capital and Corporate Purposes

Reuters
31 Jul
<a href="https://laohu8.com/S/CELU">Celularity Inc.</a> Announces $2 Million Private Placement with Institutional Investor for Working Capital and Corporate Purposes

Celularity Inc. has announced a private placement agreement with an institutional investor, involving the issuance and sale of 1,230,769 shares of Class A common stock and warrants to purchase an equal number of shares. Priced at $1.625 per share and warrant, the transaction is expected to generate gross proceeds of $2 million for the company. The warrants come with an exercise price of $1.50 per share and are valid for two years from issuance. The net proceeds from this private placement will be allocated towards working capital and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-021556), on July 30, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10